These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 27648082

  • 21. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838
    [Abstract] [Full Text] [Related]

  • 22. Cosmetic effect in patients with early breast cancer treated with breast conserving therapy (BCT) and with HDR brachytherapy (HDR-BT) "boost".
    Kulik A, Łyczek J, Kawczyn Ska M, Gruszczyn Ska E.
    J Contemp Brachytherapy; 2009 Jun 01; 1(2):77-86. PubMed ID: 27795716
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. High-dose-rate interstitial brachytherapy vs external beam radiation for the treatment of complex keloids.
    Liao Y, Dorafshar AH, Bernard D, Kim T, Camden NB, Wang D.
    Med Dosim; 2009 Jun 01; 47(2):158-160. PubMed ID: 35264302
    [Abstract] [Full Text] [Related]

  • 26. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D, Hopfgartner J, Gòra J, Kuess P, Kragl G, Berger D, Hegazy N, Goldner G, Georg P.
    Int J Radiat Oncol Biol Phys; 2014 Mar 01; 88(3):715-22. PubMed ID: 24521685
    [Abstract] [Full Text] [Related]

  • 27. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P, Dietrich J, Ostertag H, Schmid A, Kohr P, Kimmig B, Kovács G.
    Strahlenther Onkol; 2006 Feb 01; 182(2):102-7. PubMed ID: 16447017
    [Abstract] [Full Text] [Related]

  • 28. Individualized Dose-Escalation of HDR Prostate Brachytherapy Implant to Decrease Required External Beam Radiation Dose: A Retrospective Feasibility Study.
    Dahn HM, Oliver PAK, Allen S, Cherpak A, Syme A, Patil N, Bowes D.
    Adv Radiat Oncol; 2019 Feb 01; 4(4):641-648. PubMed ID: 31673657
    [Abstract] [Full Text] [Related]

  • 29. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
    Ecke TH, Huang-Tiel HJ, Golka K, Selinski S, Geis BC, Koswig S, Bathe K, Hallmann S, Gerullis H.
    Int J Mol Sci; 2016 Nov 10; 17(11):. PubMed ID: 27834929
    [Abstract] [Full Text] [Related]

  • 30. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer.
    Pellizzon AC, Nadalin W, Salvajoli JV, Fogaroli RC, Novaes PE, Maia MA, Ferrigno R.
    Radiother Oncol; 2003 Feb 10; 66(2):167-72. PubMed ID: 12648788
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
    Fang FM, Wang YM, Wang CJ, Huang HY, Chiang PH.
    Jpn J Clin Oncol; 2008 Jul 10; 38(7):474-9. PubMed ID: 18621848
    [Abstract] [Full Text] [Related]

  • 32. Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer.
    Resch A, Pötter R, Van Limbergen E, Biber E, Klein T, Fellner C, Handl-Zeller L, Langbauer G, Schürer-Waldheim H, Staffen A, Jakesz R, Kubista E, Lehr S, Seitz W.
    Radiother Oncol; 2002 Apr 10; 63(1):47-58. PubMed ID: 12065103
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Accelerated partial breast irradiation using external beam radiotherapy-A feasibility study based on dosimetric analysis.
    Anbumani S, Palled SR, Prabhakar GS, Nambiraj NA, Pichandi A.
    Rep Pract Oncol Radiother; 2012 Apr 10; 17(4):200-6. PubMed ID: 24377024
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. High-dose-rate brachytherapy boost for prostate cancer: Comparison of three different fractionation schemes.
    Falk AT, Demontoy S, Chamorey E, Chand ME, Gautier M, Azria D, Zaki S, Chevallier D, Cham Kee DL, Hannoun-Lévi JM.
    Brachytherapy; 2017 Apr 10; 16(5):993-999. PubMed ID: 28754301
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.